Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20829414 | 0.89 | AHR (0.32) | TSHRACHE | |
| SCHEMBL20653685 | 0.86 | — | — | |
| SCHEMBL20653585 | 0.79 | ESR1 (0.34) | — | |
| SCHEMBL20653584 | 0.79 | — | — | |
| SCHEMBL24858835 | 0.77 | CYP2A6 (0.35) | TSHRACHECYP2A6ALDH1A1CYP1A2 | |
| SCHEMBL20653605 | 0.77 | — | — | |
| SCHEMBL20653612 | 0.75 | — | — | |
| SCHEMBL24858845 | 0.74 | MEN1 (0.35) | TSHRACHECYP2A6ALDH1A1CYP1A2 | |
| SCHEMBL20653600 | 0.74 | — | — | |
| SCHEMBL20653599 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230122208-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-20 | — | — | US | disclosed |
| US-11548905-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230122208-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ZYX, SLC39A3, SOD3 | TSHR 1596/4885ACHE 2249/4885CYP2A6 4304/4885 |
| US-11548905-B2 | Organic electroluminescent materials and devices | ZYX, SLC39A3, SOD3 | TSHR 1596/4885ACHE 2249/4885CYP2A6 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.